Renaissance Technologies’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-13,164
Closed -$46.6K 3981
2024
Q3
$46.6K Sell
13,164
-11,700
-47% -$41.4K ﹤0.01% 3352
2024
Q2
$68.9K Sell
24,864
-20,200
-45% -$56K ﹤0.01% 3245
2024
Q1
$299K Buy
45,064
+17,045
+61% +$113K ﹤0.01% 3091
2023
Q4
$85K Buy
28,019
+9,055
+48% +$27.5K ﹤0.01% 3345
2023
Q3
$29K Buy
18,964
+3,100
+20% +$4.74K ﹤0.01% 3478
2023
Q2
$28K Buy
15,864
+3,200
+25% +$5.65K ﹤0.01% 3720
2023
Q1
$16K Buy
12,664
+2,100
+20% +$2.65K ﹤0.01% 3851
2022
Q4
$25K Buy
10,564
+1,029
+11% +$2.44K ﹤0.01% 3931
2022
Q3
$39K Buy
9,535
+3,775
+66% +$15.4K ﹤0.01% 3813
2022
Q2
$30K Buy
5,760
+2,835
+97% +$14.8K ﹤0.01% 4080
2022
Q1
$30K Sell
2,925
-20,597
-88% -$211K ﹤0.01% 3971
2021
Q4
$265K Sell
23,522
-13,214
-36% -$149K ﹤0.01% 3398
2021
Q3
$749K Sell
36,736
-14,820
-29% -$302K ﹤0.01% 2705
2021
Q2
$1.29M Sell
51,556
-10,969
-18% -$274K ﹤0.01% 2532
2021
Q1
$1.79M Buy
62,525
+30,806
+97% +$881K ﹤0.01% 2295
2020
Q4
$660K Sell
31,719
-28,502
-47% -$593K ﹤0.01% 2705
2020
Q3
$1.55M Sell
60,221
-8,973
-13% -$232K ﹤0.01% 2270
2020
Q2
$1.63M Buy
69,194
+45,335
+190% +$1.07M ﹤0.01% 2288
2020
Q1
$158K Sell
23,859
-695
-3% -$4.6K ﹤0.01% 3143
2019
Q4
$281K Buy
24,554
+7,542
+44% +$86.3K ﹤0.01% 3088
2019
Q3
$228K Buy
17,012
+7,185
+73% +$96.3K ﹤0.01% 3111
2019
Q2
$142K Buy
9,827
+2,661
+37% +$38.5K ﹤0.01% 3357
2019
Q1
$279K Sell
7,166
-2,883
-29% -$112K ﹤0.01% 3115
2018
Q4
$169K Buy
10,049
+7,562
+304% +$127K ﹤0.01% 3163
2018
Q3
$137K Buy
+2,487
New +$137K ﹤0.01% 3211